Latest News
Lockdown continues to weigh heavily on shop prices - BRC
Shops prices continued to fall in March, industry research showed on Wednesday, as embattled retailers discounted goods.
US close: Stocks end session lower as bond yields come back into focus
Wall Street stocks closed lower on Tuesday after the Dow Jones saw out the previous session at a fresh all-time high as elevated bond yields weighed on sentiment yet again.
Wednesday preview: Biden speech, Next in the spotlight
US President Joe Biden is expected to take the spotlight at the end of the quarter as he lays out his case for a multi-trillion dollar package of infrastructure spending in a speech in Pittsburgh.
Mitsubishi group warns of possible $300m loss
Japan’s Mitsubishi UFJ Financial Group warned on Tuesday of a potential loss of around $300m at its European subsidiary over an anonymous US client.
Europe close: Stocks extend gains, Dax hits fresh record high
European shares held gains at lunchtime on Tuesday as investors shrugged off worries over the troubles at Archegos Capital and focused on the prospects of a post Covid pandemic economic recovery.
London close: Stocks finish firmer as sterling weakens against dollar
London stocks finished in positive territory on Tuesday, as investors looked past the Archegos Capital collapse.
Aurora, Volvo partner to develop self-driving heavy trucks
Volvo announced on Tuesday it would be partnering with California-based Aurora Innovation to build self-driving heavy trucks.
Broker tips: Eqtec, Fevertree, Victrex
Analysts at Canaccord Genuity initiated coverage on bioscience energy company Eqtec with a 'speculative buy' rating on Tuesday, highlighting its "next-generation" waste gasification technology.
Barclays starts ITM Power at 'overweight', firm to be at forefront of 'decarbonisation'
Analysts at Barclays started coverage of ITM Power at 'Overweight' with an 800. 0p target price, arguing that the firm was likely to be near the forefront of many industries' and governments' decarbonisation strategies.
Director dealings: Learning Technologies director ups stake
Learning Technologies said on Tuesday that non-executive director Leslie-Ann Reed had acquired 100,000 ordinary shares in the London-listed digital learning group.
Velocys extends sustainable fuel project agreement with BA
Sustainable fuels technology company Velocys has jointly agreed to extend the current option agreement with British Airways for the ‘Altalto’ project, it announced on Tuesday, to 31 March 2022.
Microsoft to place 50,000 people in jobs through LinkedIn
Microsoft said on Tuesday that it aims to place 50,000 people in high skilled tech jobs in a push through its professional networking site LinkedIn to boost the labour market and employees affected by the pandemic.
US open: Stocks lower as bond yields advance again
Wall Street stocks were in the red early on Tuesday after the Dow Jones saw out the previous session at a fresh all-time high as elevated bond yields weighed on sentiment yet again.
Angle completes clinical labs in Guildford and Pennsylvania
Liquid biopsy company Angle has completed the fitout and staffing of its clinical services laboratories in Guildford and Pennsylvania, it announced on Tuesday.
BioNTech ups 2021 vaccine production target to 2.5bn doses
BioNTech has increased the production target for its Covid-19 vaccine, to 2. 5bn doses by the end of the year, it was confirmed on Tuesday.
FTSE 250 movers: Victrex rallies on upgrade; Pennon ticks lower
London’s FTSE 250 was up 0. 3% at 21,506. 7 in afternoon trade on Tuesday.
FTSE 100 movers: Banks gain; Imperial Brands in the red
London’s FTSE 100 was up 0. 2% at 6,746. 45 in afternoon trade on Tuesday.
Paypal launches 'Checkout with Crypto' service in the US
PayPal has launched a new ‘Checkout with Crypto’ service that will allow consumers in the US to use cryptocurrencies to check out.
Fevertree slumps after RBC downgrade
Fevertree slumped on Tuesday after RBC Capital Markets downgraded its stance on shares of the posh tonics maker to ‘sector perform’ from ‘outperform’ and slashed the price target from 2,600p.
Cambridge Cognition wins fourth schizophrenia trial contract
Cambridge Cognition has won a £1. 3m contract as the cognitive assessment partner for a schizophrenia trial, it announced on Tuesday.
Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.